Risk Factors of Hidden Blood Loss in Unilateral Biportal Endoscopic Surgery for Patients with Lumbar Spinal Stenosis
Sheng Guo, Zhiyong Yu, Chenglong Wang, Mingqiang Zhong, Rui Wang, Yechang Hu, Chunling Wang, Sen Li
Risk Factors of Hidden Blood Loss in Unilateral Biportal Endoscopic Surgery for Patients with Lumbar Spinal Stenosis
Objective: Unilateral biportal endoscopic (UBE) surgery has recently been used as a minimally invasive procedure for the treatment of lumbar spinal stenosis and is associated with less perioperative blood loss. However, perioperative hidden blood loss (HBL) may be neglected during UBE. This study aimed to examine the volume of HBL and discuss the influential risk factors for HBL during unilateral biportal endoscopic surgery.
Methods: From January 2022 to August 2022, 51 patients underwent percutaneous unilateral biportal endoscopic surgery for lumbar spinal stenosis at the Department of Spinal Surgery of the Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University and were enrolled in this study. The data included general indicators (age, sex and body mass index [BMI]), underlying disease (hypertension and diabetes), laboratory test results (prothrombin time [PT], activated partial thromboplastin time [APTT], fibrinogen [Fbg]), and preoperative and postoperative hematocrit and hemoglobin), related imaging parameters (severity of intervertebral disc [IVD] degeneration and soft tissue thickness of the interlaminar approach), number of operated vertebrae and operation time. Total blood loss (TBL) and HBL during surgical procedures were measured via the Gross formula. Influential factors were further analyzed by multivariate linear regression analysis and t-tests.
Results: The mean HBL was 257.89 ± 190.66 mL for single-operation patients and 296.58 ± 269.75 mL for two-operation patients. Patients with lower PT (p = 0.044), deeper tissue thickness (p = 0.047), and diabetes mellitus were determined to have more HBL during UBE. The operation time might also be an important factor (p = 0.047). However, sex (p = 0.265), age (p = 0.771/0.624), BMI (p = 0.655/0.664), APTT (p = 0.545/0.751), degree of degenerated IVD (p = 0.932/0.477), and hypertension (p = 0.356/0.896) were not related to HBL.
Conclusion: This study determined the different influential factors of HBL during UBE. PT, tissue thickness, and diabetes mellitus are the independent risk factors that affect HBL incidence. Long PT may decrease the volume of HBL within a certain range. Tissue thickness and diabetes mellitus can lead to an increased volume of HBL.
Hidden blood loss / Lumbar spinal stenosis / Unilateral biportal endoscopic surgery
[1] |
HallS, Bartleson JD, OnofrioBM, BakerHL, Okazaki H, O'DuffyJD. Lumbar spinal stenosis.Clinical features, diagnostic procedures, and results of surgical treatment in 68 patients. Ann Intern Med. 1985;103(2):271–275.
|
[2] |
LeeSY, KimTH, OhJK, LeeSJ, ParkMS. Lumbar stenosis: a recent update by review of literature. Asian Spine J. 2015;9(5):818–828.
|
[3] |
SulaimanWA, SinghM. Minimally invasive versus open transforaminal lumbar interbody fusion for degenerative spondylolisthesis grades 1–2: patient-reported clinical outcomes and cost-utility analysis. Ochsner J. 2014;14(1):31–37.
|
[4] |
KarikariIO, IsaacsRE. Minimally invasive transforaminal lumbar interbody fusion: a review of techniqTLIF and outcomes. Spine (Phila Pa 1976). 2010;35(26 Suppl):S294–S301.
|
[5] |
ShimaK, SonoT, KitaoriT, Takatsuka K. Substantially high hidden blood loss in oblique lateral Interbody fusion: retrospective case series. Medicina (Kaunas). 2022;58(4):527.
|
[6] |
SehatKR, EvansRL, NewmanJH. How much blood is really lost in total knee arthroplasty? Correct blood loss management should take hidden loss into account. Knee. 2000;7(3):151–155.
|
[7] |
YangY, ZhangL, LiuB, PangM, XieP, ChenZ, et al. Hidden and overall haemorrhage following minimally invasive and open transforaminal lumbar interbody fusion. J Orthop Traumatol. 2017;18(4):395–400.
|
[8] |
NelsonAR, BrownLB. Hidden hemorrhage: an uncommon complication of a common operation. Ariz Med. 1966;23(12):919–921.
|
[9] |
KimJE, ChoiDJ, ParkEJJ, Lee HJ, HwangJH, KimMC, et al. Biportal endoscopic spinal surgery for lumbar spinal stenosis. Asian Spine J. 2019;13(2):334–342.
|
[10] |
GrossJB. Estimating allowable blood loss: corrected for dilution[J]. Anesthesiology. 1983;58(3):277–280.
|
[11] |
XuB, XuH, MaX, LiuY, YangQ, Jiang H, et al. Bilateral decompression and intervertebral fusion via unilateral fenestration for complex lumbar spinal stenosis with a mobile microendoscopic technique. Medicine (Baltimore). 2018;97(4):e9715.
|
[12] |
KimN, JungSB. Percutaneous unilateral Biportal endoscopic spine surgery using a 30-degree Arthroscope in patients with severe lumbar spinal stenosis: a technical note. Clin Spine Surg. 2019;32(8):324–329.
|
[13] |
HeoDH, LeeDC, ParkCK. Comparative analysis of three types of minimally invasive decompressive surgery for lumbar central stenosis: biportal endoscopy, uniportal endoscopy, and microsurgery. Neurosurg Focus. 2019;46(5):E9.
|
[14] |
SmorgickY, BakerKC, BachisonCC, Herkowitz HN, MontgomeryDM, FischgrundJS. Hidden blood loss during posterior spine fusion surgery. Spine J. 2013;13(8):877–881.
|
[15] |
WuTM, ChoiDJ, ChangWS, Hwang JH, KimMC, KimDG. Exploring physical lumbar microvascular geometry through endoscopy and illustrations: implications for clinical interpretation. Global Spine J. 2023;28:21925682231218729.
|
[16] |
KingKB, Rosenthal AK. The adverse effects of diabetes on osteoarthritis: update on clinical evidence and molecular mechanisms. Osteoarthr Cartil. 2015 Jun;23(6):841–850.
|
[17] |
XuD, ChenX, LiZ, RenZ, ZhuangQ, Li S. Tranexamic acid reduce hidden blood loss in posterior lumbar interbody fusion (PLIF) surgery. Medicine. 2020;99(11):e19552.
|
[18] |
ZhangS, XiaoC, YuW, LongN, HeF, CaiP, et al. Tranexamic acid safely reduces hidden blood loss in patients undergoing intertrochanteric fracture surgery: a randomized controlled trial. Eur J Trauma Emerg Surg. 2022;48(2):731–741.
|
[19] |
PATCH-Trauma Investigators and the ANZICS Clinical Trials Group, GruenRL, Mitra B, BernardSA, McArthurCJ, BurnsB, et al. Prehospital Tranexamic acid for severe trauma. N Engl J Med. 2023;389(2):127–136.
|
[20] |
GolshaniK, FerrelA, LessneM, Shah P, ChowdharyA, ChoulakianA, et al. Stent-assisted coil emboilization of ruptured intracranial aneurysms: a retrospective multicenter review. Surg Neurol Int. 2012;3:84.
|
/
〈 | 〉 |